Catherine Roche‐Lestienne
- Hematology top 0.5%
- Genetics top 0.5%
- Molecular Biology
- Rheumatology top 2%
- Pathology and Forensic Medicine top 5%
- Co-authors
- Claude PreudhommeThierry FaçonN PhilippeValérie SoenenNathalie GrardelJean-Luc Laı̈Pierre FenauxBruno Quesnel
- Topics
- Chronic Myeloid Leukemia Treatments (27 papers)Chronic Lymphocytic Leukemia Research (25 papers)Acute Myeloid Leukemia Research (18 papers)
- Cited by
- HematologyGeneticsRheumatology
- Partner nations
- FranceGermanyUnited States
In The Last Decade
Catherine Roche‐Lestienne
64 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 94
- Hematology 1.2k
- Genetics 1.0k
- Molecular Biology 534
- Rheumatology 478
- Pathology and Forensic Medicine 368
Countries citing papers authored by Catherine Roche‐Lestienne
This map shows the geographic impact of Catherine Roche‐Lestienne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine Roche‐Lestienne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine Roche‐Lestienne more than expected).
Fields of papers citing papers by Catherine Roche‐Lestienne
This network shows the impact of papers produced by Catherine Roche‐Lestienne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine Roche‐Lestienne. The network helps show where Catherine Roche‐Lestienne may publish in the future.
Co-authorship network of co-authors of Catherine Roche‐Lestienne
This figure shows the co-authorship network connecting the top 25 collaborators of Catherine Roche‐Lestienne. A scholar is included among the top collaborators of Catherine Roche‐Lestienne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine Roche‐Lestienne. Catherine Roche‐Lestienne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 2 | |
| 3 | 89 | |
| 4 | 62 | |
| 5 | 4 | |
| 6 | 6 | |
| 7 | L'essentiel du droit de l'environnement | 2 |
| 8 | 10 | |
| 9 | 15 | |
| 10 | 33 | |
| 11 | 1 | |
| 12 | 8 | |
| 13 | 51 | |
| 14 | Droit de l'environnement | 2 |
| 15 | 154 | |
| 16 | 2 | |
| 17 | 57 | |
| 18 | 51 | |
| 19 | 25 | |
| 20 | 21 |
About Catherine Roche‐Lestienne
Catherine Roche‐Lestienne is a scholar working on Hematology, Genetics and Rheumatology, having authored 69 papers that have together received 2.0k indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (27 papers), Chronic Lymphocytic Leukemia Research (25 papers) and Acute Myeloid Leukemia Research (18 papers). The work is most often cited by research in Hematology (1.2k citations), Genetics (1.0k citations) and Rheumatology (478 citations). Catherine Roche‐Lestienne has collaborated with scholars based in France, Germany and United States. Frequent co-authors include Claude Preudhomme, Thierry Façon, N Philippe, Valérie Soenen, Nathalie Grardel, Jean-Luc Laı̈, Pierre Fenaux, Bruno Quesnel, Aline Renneville and Sélim Corm. Their work appears in journals such as Blood, Cancer and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.